Which has higher valuation & earnings, TBIO or BFRGW?

Bullfrog AI has lower revenue, but higher earnings than Telesis Bio. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Telesis Bio $225.09M 0.00 -$47.72M -$20.52 N/A Bullfrog AI $298.80K N/A N/A N/A N/A

Is TBIO or BFRGW more profitable?

Bullfrog AI has a net margin of 0.00% compared to Telesis Bio's net margin of -336.59%. Company Net Margins Return on Equity Return on Assets Telesis Bio -336.59% N/A -61.89% Bullfrog AI N/A N/A N/A

Which has higher earnings & valuation, OABIW or TBIO?

OmniAb has higher earnings, but lower revenue than Telesis Bio. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio OmniAb $38.46M N/A N/A N/A N/A Telesis Bio $225.09M 0.00 -$47.72M -$20.52 N/A

Is OABIW or TBIO more profitable?

OmniAb has a net margin of 0.00% compared to Telesis Bio's net margin of -336.59%. Company Net Margins Return on Equity Return on Assets OmniAb N/A N/A N/A Telesis Bio -336.59% N/A -61.89%

Do analysts recommend TBIO or DHR?

Danaher has a consensus price target of $229.32, suggesting a potential upside of 3.39%. Given Danaher's stronger consensus rating and higher probable upside, analysts plainly believe Danaher is more favorable than Telesis Bio. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Telesis Bio 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Danaher 0 Sell rating(s) 5 Hold rating(s) 17 Buy rating(s) 2 Strong Buy rating(s) 2.88

Which has better earnings and valuation, TBIO or DHR?

Danaher has higher revenue and earnings than Telesis Bio. Telesis Bio is trading at a lower price-to-earnings ratio than Danaher, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Telesis Bio $225.09M 0.00 -$47.72M -$20.52 N/A Danaher $24.57B 6.35 $3.61B $5.63 39.40

Is TBIO or DHR more profitable?

Danaher has a net margin of 15.95% compared to Telesis Bio's net margin of -336.59%. Danaher's return on equity of 11.04% beat Telesis Bio's return on equity. Company Net Margins Return on Equity Return on Assets Telesis Bio -336.59% N/A -61.89% Danaher 15.95% 11.04% 6.81%

Do analysts prefer IQV or TBIO?

IQVIA currently has a consensus target price of $248.00, suggesting a potential downside of 7.48%. Given IQVIA's stronger consensus rating and higher probable upside, equities analysts clearly believe IQVIA is more favorable than Telesis Bio. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score IQVIA 0 Sell rating(s) 3 Hold rating(s) 13 Buy rating(s) 1 Strong Buy rating(s) 2.88 Telesis Bio 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has higher earnings and valuation, IQV or TBIO?

IQVIA has higher revenue and earnings than Telesis Bio. Telesis Bio is trading at a lower price-to-earnings ratio than IQVIA, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio IQVIA $16.31B 2.71 $1.36B $8.06 33.26 Telesis Bio $225.09M 0.00 -$47.72M -$20.52 N/A

Is IQV or TBIO more profitable?

IQVIA has a net margin of 8.10% compared to Telesis Bio's net margin of -336.59%. IQVIA's return on equity of 30.25% beat Telesis Bio's return on equity. Company Net Margins Return on Equity Return on Assets IQVIA 8.10% 30.25% 6.54% Telesis Bio -336.59% N/A -61.89%

Telesis Bio (TBIO) Competitors

$0.01 +0.01 (+1,000.00%)

As of 09:31 AM Eastern

Compare

TBIO vs. BFRGW, OABIW, TMO, DHR, and IQV

Should you buy Telesis Bio stock or one of its competitors? Telesis Bio's main competitors and comparable companies include Bullfrog AI (BFRGW), OmniAb (OABIW), Thermo Fisher Scientific (TMO), Danaher (DHR), and IQVIA (IQV). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "life sciences tools & services" industry.

How does Telesis Bio compare to Bullfrog AI?

Telesis Bio (NASDAQ:TBIO) and Bullfrog AI (NASDAQ:BFRGW) are both healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, valuation, analyst recommendations, earnings, media sentiment, institutional ownership, risk and dividends.

Bullfrog AI has lower revenue, but higher earnings than Telesis Bio.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Telesis Bio	$225.09M	0.00	-$47.72M	-$20.52	N/A
Bullfrog AI	$298.80K	N/A	N/A	N/A	N/A

In the previous week, Telesis Bio's average media sentiment score of 0.00 equaled Bullfrog AI'saverage media sentiment score.

Company	Overall Sentiment
Telesis Bio	Neutral
Bullfrog AI	Neutral

37.6% of Telesis Bio shares are held by institutional investors. 24.5% of Telesis Bio shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Bullfrog AI has a net margin of 0.00% compared to Telesis Bio's net margin of -336.59%.

Company	Net Margins	Return on Equity	Return on Assets
Telesis Bio	-336.59%	N/A	-61.89%
Bullfrog AI	N/A	N/A	N/A

Summary

Telesis Bio beats Bullfrog AI on 3 of the 5 factors compared between the two stocks.

How does Telesis Bio compare to OmniAb?

OmniAb (NASDAQ:OABIW) and Telesis Bio (NASDAQ:TBIO) are both healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, valuation, earnings, risk, analyst recommendations and media sentiment.

In the previous week, OmniAb's average media sentiment score of 0.00 equaled Telesis Bio'saverage media sentiment score.

Company	Overall Sentiment
OmniAb	Neutral
Telesis Bio	Neutral

OmniAb has higher earnings, but lower revenue than Telesis Bio.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OmniAb	$38.46M	N/A	N/A	N/A	N/A
Telesis Bio	$225.09M	0.00	-$47.72M	-$20.52	N/A

37.6% of Telesis Bio shares are owned by institutional investors. 24.5% of Telesis Bio shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

OmniAb has a net margin of 0.00% compared to Telesis Bio's net margin of -336.59%.

Company	Net Margins	Return on Equity	Return on Assets
OmniAb	N/A	N/A	N/A
Telesis Bio	-336.59%	N/A	-61.89%

Summary

Telesis Bio beats OmniAb on 3 of the 5 factors compared between the two stocks.

How does Telesis Bio compare to Thermo Fisher Scientific?

Thermo Fisher Scientific (NYSE:TMO) and Telesis Bio (NASDAQ:TBIO) are both healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, valuation, analyst recommendations, risk, media sentiment, institutional ownership, earnings and profitability.

Thermo Fisher Scientific has a net margin of 15.04% compared to Telesis Bio's net margin of -336.59%. Thermo Fisher Scientific's return on equity of 17.09% beat Telesis Bio's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Thermo Fisher Scientific	15.04%	17.09%	8.12%
Telesis Bio	-336.59%	N/A	-61.89%

Thermo Fisher Scientific currently has a consensus target price of $624.64, suggesting a potential downside of 6.18%. Given Thermo Fisher Scientific's stronger consensus rating and higher possible upside, equities analysts plainly believe Thermo Fisher Scientific is more favorable than Telesis Bio.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Thermo Fisher Scientific	2 Sell rating(s)	5 Hold rating(s)	17 Buy rating(s)	2 Strong Buy rating(s)	2.73
Telesis Bio	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

89.2% of Thermo Fisher Scientific shares are held by institutional investors. Comparatively, 37.6% of Telesis Bio shares are held by institutional investors. 0.3% of Thermo Fisher Scientific shares are held by insiders. Comparatively, 24.5% of Telesis Bio shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Thermo Fisher Scientific has higher revenue and earnings than Telesis Bio. Telesis Bio is trading at a lower price-to-earnings ratio than Thermo Fisher Scientific, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Thermo Fisher Scientific	$44.56B	5.52	$6.70B	$18.59	35.81
Telesis Bio	$225.09M	0.00	-$47.72M	-$20.52	N/A

In the previous week, Thermo Fisher Scientific had 24 more articles in the media than Telesis Bio. MarketBeat recorded 24 mentions for Thermo Fisher Scientific and 0 mentions for Telesis Bio. Thermo Fisher Scientific's average media sentiment score of 1.00 beat Telesis Bio's score of 0.00 indicating that Thermo Fisher Scientific is being referred to more favorably in the media.

Company	Overall Sentiment
Thermo Fisher Scientific	Positive
Telesis Bio	Neutral

Thermo Fisher Scientific has a beta of 0.85, indicating that its stock price is 15% less volatile than the broader market. Comparatively, Telesis Bio has a beta of 2.47, indicating that its stock price is 147% more volatile than the broader market.

Summary

Thermo Fisher Scientific beats Telesis Bio on 15 of the 17 factors compared between the two stocks.

How does Telesis Bio compare to Danaher?

Telesis Bio (NASDAQ:TBIO) and Danaher (NYSE:DHR) are both healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, risk, dividends, institutional ownership, profitability, valuation, analyst recommendations and media sentiment.

Danaher has a consensus price target of $229.32, suggesting a potential upside of 3.39%. Given Danaher's stronger consensus rating and higher probable upside, analysts plainly believe Danaher is more favorable than Telesis Bio.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Telesis Bio	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Danaher	0 Sell rating(s)	5 Hold rating(s)	17 Buy rating(s)	2 Strong Buy rating(s)	2.88

Danaher has a net margin of 15.95% compared to Telesis Bio's net margin of -336.59%. Danaher's return on equity of 11.04% beat Telesis Bio's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Telesis Bio	-336.59%	N/A	-61.89%
Danaher	15.95%	11.04%	6.81%

In the previous week, Danaher had 7 more articles in the media than Telesis Bio. MarketBeat recorded 7 mentions for Danaher and 0 mentions for Telesis Bio. Danaher's average media sentiment score of 0.74 beat Telesis Bio's score of 0.00 indicating that Danaher is being referred to more favorably in the news media.

Company	Overall Sentiment
Telesis Bio	Neutral
Danaher	Positive

Telesis Bio has a beta of 2.47, indicating that its stock price is 147% more volatile than the broader market. Comparatively, Danaher has a beta of 0.78, indicating that its stock price is 22% less volatile than the broader market.

Danaher has higher revenue and earnings than Telesis Bio. Telesis Bio is trading at a lower price-to-earnings ratio than Danaher, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Telesis Bio	$225.09M	0.00	-$47.72M	-$20.52	N/A
Danaher	$24.57B	6.35	$3.61B	$5.63	39.40

37.6% of Telesis Bio shares are held by institutional investors. Comparatively, 79.1% of Danaher shares are held by institutional investors. 24.5% of Telesis Bio shares are held by company insiders. Comparatively, 10.8% of Danaher shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Summary

Danaher beats Telesis Bio on 15 of the 17 factors compared between the two stocks.

How does Telesis Bio compare to IQVIA?

IQVIA (NYSE:IQV) and Telesis Bio (NASDAQ:TBIO) are both healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, profitability, risk, institutional ownership, valuation, dividends, analyst recommendations and media sentiment.

IQVIA has a beta of 1.18, indicating that its share price is 18% more volatile than the broader market. Comparatively, Telesis Bio has a beta of 2.47, indicating that its share price is 147% more volatile than the broader market.

IQVIA has a net margin of 8.10% compared to Telesis Bio's net margin of -336.59%. IQVIA's return on equity of 30.25% beat Telesis Bio's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
IQVIA	8.10%	30.25%	6.54%
Telesis Bio	-336.59%	N/A	-61.89%

89.6% of IQVIA shares are owned by institutional investors. Comparatively, 37.6% of Telesis Bio shares are owned by institutional investors. 1.7% of IQVIA shares are owned by insiders. Comparatively, 24.5% of Telesis Bio shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

IQVIA currently has a consensus target price of $248.00, suggesting a potential downside of 7.48%. Given IQVIA's stronger consensus rating and higher probable upside, equities analysts clearly believe IQVIA is more favorable than Telesis Bio.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IQVIA	0 Sell rating(s)	3 Hold rating(s)	13 Buy rating(s)	1 Strong Buy rating(s)	2.88
Telesis Bio	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

In the previous week, IQVIA had 10 more articles in the media than Telesis Bio. MarketBeat recorded 10 mentions for IQVIA and 0 mentions for Telesis Bio. IQVIA's average media sentiment score of 0.57 beat Telesis Bio's score of 0.00 indicating that IQVIA is being referred to more favorably in the media.

Company	Overall Sentiment
IQVIA	Positive
Telesis Bio	Neutral

IQVIA has higher revenue and earnings than Telesis Bio. Telesis Bio is trading at a lower price-to-earnings ratio than IQVIA, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IQVIA	$16.31B	2.71	$1.36B	$8.06	33.26
Telesis Bio	$225.09M	0.00	-$47.72M	-$20.52	N/A

Summary

IQVIA beats Telesis Bio on 15 of the 17 factors compared between the two stocks.

Get Telesis Bio News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TBIO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

TBIO vs. The Competition

Export

Metric	Telesis Bio	Life Sciences Tools & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$20K	$10.52B	$7.21B	$13.10B
Dividend Yield	N/A	1.45%	2.53%	13.00%
P/E Ratio	0.00	73.29	274.58	25.69
Price / Sales	0.00	108.37	639.38	80.65
Price / Cash	N/A	27.60	76.31	52.02
Price / Book	0.08	5.82	10.44	6.32
Net Income	-$47.72M	$56.67B	$3.49B	$359.73M
7 Day Performance	N/A	4.39%	0.51%	1.35%
1 Month Performance	N/A	2.47%	-3.38%	-3.68%
1 Year Performance	N/A	28.33%	16.04%	5.56%

Telesis Bio Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
TBIO Telesis Bio	N/A	$0.01 +1,000.0%	N/A	+0.0%	$20K	$225.09M	N/A	200	Gap Up
BFRGW Bullfrog AI	N/A	$0.09 +4.9%	N/A	-81.4%	$0.00	$298.80K	N/A	2	News Coverage Positive News Gap Up
OABIW OmniAb	N/A	$0.22 -40.7%	N/A	+20.7%	$0.00	$38.46M	N/A	106
TMO Thermo Fisher Scientific	3.7904 of 5 stars	$649.14 +1.2%	$624.64 -3.8%	+38.9%	$237.15B	$44.56B	34.92	125,000	Trending News
DHR Danaher	3.1716 of 5 stars	$208.46 -0.4%	$228.91 +9.8%	+16.2%	$147.18B	$24.57B	37.03	60,000

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:TBIO) was last updated on 9/23/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Telesis Bio (TBIO) Competitors

TBIO vs. BFRGW, OABIW, TMO, DHR, and IQV

How does Telesis Bio compare to Bullfrog AI?

Summary

How does Telesis Bio compare to OmniAb?

Summary

How does Telesis Bio compare to Thermo Fisher Scientific?

Summary

How does Telesis Bio compare to Danaher?

Summary

How does Telesis Bio compare to IQVIA?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TBIO vs. The Competition

Telesis Bio Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Telesis Bio (TBIO) Competitors

TBIO vs. BFRGW, OABIW, TMO, DHR, and IQV

How does Telesis Bio compare to Bullfrog AI?

Which has higher valuation & earnings, TBIO or BFRGW?

Does the media prefer TBIO or BFRGW?

Do institutionals and insiders hold more shares of TBIO or BFRGW?

Is TBIO or BFRGW more profitable?

Summary

How does Telesis Bio compare to OmniAb?

Does the media prefer OABIW or TBIO?

Which has higher earnings & valuation, OABIW or TBIO?

Do insiders and institutionals have more ownership in OABIW or TBIO?

Is OABIW or TBIO more profitable?

Summary

How does Telesis Bio compare to Thermo Fisher Scientific?

Is TMO or TBIO more profitable?

Do analysts prefer TMO or TBIO?

Do insiders & institutionals hold more shares of TMO or TBIO?

Which has higher valuation and earnings, TMO or TBIO?

Does the media prefer TMO or TBIO?

Which has more volatility & risk, TMO or TBIO?

Summary

How does Telesis Bio compare to Danaher?

Do analysts recommend TBIO or DHR?

Is TBIO or DHR more profitable?

Does the media refer more to TBIO or DHR?

Which has more risk and volatility, TBIO or DHR?

Which has better earnings and valuation, TBIO or DHR?

Do insiders & institutionals hold more shares of TBIO or DHR?

Summary

How does Telesis Bio compare to IQVIA?

Which has more risk & volatility, IQV or TBIO?

Is IQV or TBIO more profitable?

Do institutionals & insiders hold more shares of IQV or TBIO?

Do analysts prefer IQV or TBIO?

Does the media refer more to IQV or TBIO?

Which has higher earnings and valuation, IQV or TBIO?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TBIO vs. The Competition

Telesis Bio Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools